NCT06826716View on ClinicalTrials.gov

A Study to Assess the Effect of Libifem® (VL-GF-01) on Fertility in Women With Diminished Ovarian Reserve

NANot yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

February 10, 2025

Primary Completion Date

December 5, 2025

Study Completion Date

December 10, 2025

Conditions
Female Fertility
Interventions
DIETARY_SUPPLEMENT

Fenugreek (Trigonella foenum graecum)

"Dose: 600 mg/day Regimen:~One capsule (300 mg) to be taken twice a day 30 minutes post breakfast and dinner Route of administration: Oral"

DIETARY_SUPPLEMENT

Placebo (Maltodextrin)

"Dose: 600 mg/day Regimen:~One capsule (300 mg) to be taken twice a day 30 minutes post breakfast and dinner Route of administration: Oral"

Trial Locations (7)

110053

Panchsheel Hospital Pvt. Ltd., Delhi

221005

Pragya Mother & Child care Hospital, Varanasi

302017

Jnu ,Jaipur, Jaipur

380008

Sachi Hospital, Ahmedabad

411033

Ashwin Medical Foundations Moraya Multispeciality Hospita, Pune

380018.

Shardaben General Hospital, Ahmedabad

411062.

Imperial Multispeciality Hospital, Pune

All Listed Sponsors
lead

Vedic Lifesciences Pvt. Ltd.

INDUSTRY

NCT06826716 - A Study to Assess the Effect of Libifem® (VL-GF-01) on Fertility in Women With Diminished Ovarian Reserve | Biotech Hunter | Biotech Hunter